Global Neurovascular Devices Market Outlook To 2026: Key Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm), Device Type (Cerebral embolization and aneurysm coiling devices, Cerebral angioplasty and stenting systems, Neurothrombectomy devices, Support devices), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast And Conclusion

$3,650.00$6,650.00

Clear
  • Report Description
  • Table of Content
  • Highlight
  • Research Methodology
  • Request Free Sample

The Neurovascular Devices Market was valued at $2.08Million in 2018 and is forecast to grow at a modest5.5 % CAGR between2018 and 2025, culminating in 2026 global sales of $3.8Billion.

 

Neurovascular devices help in the treatment of several neurovascular disorders like intracranial atherosclerotic and cerebral aneurysm disease. The upsurge in the geriatric population and increase in a number of patients suffering from neurovascular disorders are anticipated to drive the market growth. Additionally, growth in acceptance of new minimally invasive techniques, for example, carotid artery stenting,and flow diversion lift the market growth. So, the high cost of the medical devices and lack of neurosurgeons are projected to boost the market growth. According to WHO there are 800,000 people are suffering from strokes which are the fourth leading mortality factor in the U.S. in between them 76% people are having 65 ages and over is anticipated to grow by 59% from 800 million people in 2018 to 1.8 billion by 2028. Governing policies about medical devices fluctuate in different countries. To confirm maximum availability and safe procedure of medical devices, the union of guidelines for these devices is important. In Minimally invasive surgery helps to the patients as well as less blood loss, decrease pain, and cost-effectiveness will upsurge acceptance of neurovascular surgeries and the market growth. Some Major companies concentrating on new product launches by implementing innovative technologies to acquire market profits with better disease treatment.

Neurovascular Devices Market

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Global Neurovascular Devices”

 

Estimated Average product/ service cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

Due to the wide array of products available in the market, pricing, positioning, and sales channel optimization play a vital role in the success of a product. On average, in the China Global Neurovascular Devices are available at USD xxx- USD xxxx. However, high-end products are available at much higher prices. The prices in emerging countries and developed countries vary significantly due to the difference in purchasing power and availability of latest products.

 

Global Neurovascular DevicesMarket by “Application”

 

We have segmented the Global Neurovascular Devices based on Application as Stroke, Cerebral Artery Stenosis, and Cerebral Aneurysm.

 

We have observed that the rapid growth of Neurovascular Devices followed by Strokes Segment with 48%of the market shares over the forecast period. Due to the increase of motor impairment, people lost their function of arteries. There are 16 million people were affected by stroke per year which is expected to propel the neurovascular devices due to swift product revolutions by several companies in the upcoming years.

 

We also noticed that the significant growth of Neurovascular Devices followed by cerebral Aneurysm with a CAGR of 6.2% market share in 2018. Basically, 5% of people are suffering from this disease which may cause brain damage.

 

Global Neurovascular Devices Market by “Device Type”

 

We have segmented the Global Neurovascular Devices based on Device Type as Cerebral embolization and aneurysm coiling devices, Cerebral angioplasty and stenting systems, Neurothrombectomy devices, and Support devices.

 

We have observed that the rapid growth of Neurovascular Devices followed by Cerebral embolization and aneurysm coiling devices with 39% of the total revenue share over the forecast period. Due to the geriatric population and the occurrence of cerebrovascular disorders will help to develop this segment. Neurothrombectomy products are mainly used for patients who are unable for tissue plasminogen. These medical devices regain or destroy blood clots in the aneurysms by mechanical ultrasound techniques or lasers.

 

Regional Segmentation

 

The Asia Pacific and North America accounted for the maximum revenue share of over xx% in 2018 due to increased demand of Global Neurovascular Device followed by EU- Top 5 countries contribute $X.6 Billion in 2018 and expected to reach $x.5 Billion by 2026.

 

The rapid growth strokes and the availability of Global Neurovascular Devices materials option create an impact in developing countries for the demand for better health care device. China market will spectator health market growth at 4.9% CAGR during the forecast period. The growing burden of the aging population in China, that enhance the risk of stroke, aneurysm, and stenosis, drive the demand for neurovascular devices. According to Population and Migration data, the geriatric population in China is estimated to reach 2,387,792 by 2026. Furthermore, increasing R&D activities on neurovascular devices can support Chinese neurovascular devices market growth in the coming years. North America accounted for the largest market share of the total market in 2018. According to BAF(Brain Aneurysm Foundation), there are 6 million Americans suffer from an unruptured brain aneurysm. So, sophisticated healthcare infrastructure and advanced technology will propel the U.S. market over the forecast period.

 

“Competitive Landscape”and “Merger& Acquisition Insights”

 

The key market participants bbott Laboratories, W. L. Gore & Associates, Inc., Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Stryker Corp.,and Terumo Medical Corporation are few major players in Global Neurovascular Devices markets. TheGlobal Neurovascular Devices marketis fragmented with a large number of global & local players. Merger &Acquisitions, collaborations & new products launch are some of the major strategies adopted by key market players. Apart from this innovation& new product development are a major focus area for dominant companies.

 

Market Segmentation

 

Global Neurovascular DevicesMarket byApplication(Revenue, Million, 2018 – 2026)

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm

 

Global Neurovascular Devices Market by Device Type (Revenue, Million, 2018 – 2026)

  • Cerebral embolization and aneurysm coiling devices
  • Cerebral angioplasty and stenting systems
  • Neurothrombectomy devices
  • Support devices

 

Global Neurovascular Devices Market Regional Outlook (Revenue, USD Million, 2018-2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Global Neurovascular Devices Market Market Analytics,Global Neurovascular Devices Market Market Share, Global Neurovascular Devices Market Market Research,Global Neurovascular Devices Market Market Forecast, Global Neurovascular Devices Market Market Analysis,Global Neurovascular Devices Market Market Value, Global Neurovascular Devices Market Market Insight,Global Neurovascular Devices Market Market Trend, Global Neurovascular Devices Market Market Size,Global Neurovascular Devices Market Market Survey, Global Neurovascular Devices Market Market Research Report

Chapter 1 Methodology and Scope

  • Research Methodology
  • Research Scope & Assumptions
  • List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Neurovascular Devices Market Overview

  • Market Ecosystem
  • Key Stakeholders
  • Industry Trends & Analysis

Chapter 4 Neurovascular Devices Trend Outlook

  • Market Overview
  • Market Segmentation
  • Market Size and Growth Prospects
  • Leading Brand Dynamics
  • Key Market Drivers
    • Increasing geriatric population
    • Demand for minimally invasive medical procedures
    • Unhealthy lifestyle
    • Technological advancements
  • Key Market Challenges
  • Complex regulatory framework
  • Lack of supportive reimbursement coverage
  • Key Opportunities Prioritized
  • Industry Analysis - Porter’s
  • Neurovascular Devices Market-PESTEL Analysis

Chapter 5: -Neurovascular Devices Market by “Application” (USD Million)

Neurovascular Devices Market Landscape by Application- 2018-2026
  • Stroke
    • Market Landscape Analysis, 2018-2026
  • Cerebral Artery Stenosis
    • Market Landscape Analysis, 2018-2026
  • Cerebral Aneurysm
    • Market Landscape Analysis, 2018-2026

Chapter 6: -Neurovascular Devices Market by “Device Type” (USD Million)

Neurovascular Devices Market Landscape by Device Type - 2018-2026
  • Cerebral embolization and aneurysm coiling devices
    • Market Landscape Analysis, 2018-2026
  • Cerebral angioplasty and stenting systems
    • Market Landscape Analysis, 2018-2026
  • Neurothrombectomy devices
    • Market Landscape Analysis, 2018-2026
  • Support devices
    • Market Landscape Analysis, 2018-2026

Chapter 8: Regional Market Outlook

Neurovascular Devices Market Landscape by Region- 2018
  • North America Market Landscape Analysis, 2018-2026 (USD Mn)
    • U.S. Market Landscape Analysis, 2018-2026
    • Canada Market Landscape Analysis-2018-2026
  • Europe Market Landscape Analysis, 2018-2026 (USD Mn)
    • UK Market Landscape Analysis, 2018-2026
    • Germany Market Landscape Analysis, 2018-2026
    • France Market Landscape Analysis, 2018-2026
    • Italy Market Landscape Analysis, 2018-2026
    • Spain Market Landscape Analysis, 2018-2026
  • Latin America Market Landscape Analysis, 2018-2026 (USD Mn)
    • Brazil Market Landscape Analysis, 2018-2026
    • Mexico Market Landscape Analysis, 2018-2026
    • Colombia Market Landscape Analysis, 2018-2026
  • Asia Pacific Market Landscape Analysis, 2018-2026 (USD Mn)
    • Japan Market Landscape Analysis, 2018-2026
    • China Market Landscape Analysis, 2018-2026
    • India Market Landscape Analysis, 2018-2026
  • Middle East & Africa Market Landscape Analysis, 2018-2026 (USD Mn)
    • Saudi Arabia Market Landscape Analysis, 2018-2026
    • South Africa Market Landscape Analysis, 2018-2026

Chapter 9: Pricing Analysis

Optimal Price Points (OPP), Indifference price points (IPP) and Range of Acceptable Prices and (RAP) of leading brands by Region- 2018
  • North America Pricing Analysis (OPP, IPP, and RAP - 2018)
    • U.S. Pricing Analysis-2018
    • Canada Pricing Analysis-2018
  • Europe Pricing Analysis (OPP, IPP, and RAP - 2018)
    • UK Pricing Analysis-2018
    • Germany Pricing Analysis-2018
    • France Pricing Analysis-2018
    • Italy Pricing Analysis-2018
    • Spain Pricing Analysis-2018
  • Latin America Pricing Analysis (OPP, IPP, and RAP - 2018)
    • Brazil Pricing Analysis-2018
    • Mexico Pricing Analysis-2018
    • Colombia Pricing Analysis-2018
  • Asia Pacific Pricing Analysis (OPP, IPP, and RAP - 2018)
    • Japan Pricing Analysis-2018
    • China Pricing Analysis-2018
    • India Pricing Analysis-2018
  • Middle East Pricing Analysis (OPP, IPP, and RAP - 2018)
    • Saudi Arabia Pricing Analysis-2018
    • South Africa Pricing Analysis-2018

Chapter 10: Neurovascular DevicesPipeline Analysis

  • Executive Summary
  • Late Stage Pipeline analysis
  • Key R&D trends

Chapter 11: Neurovascular DevicesMerger &Acquisition Outlook

  • Factors driving M&A in Neurovascular Devices market
  • Key trends and future outlook

Chapter 12: Competitive Landscape

  • bbott Laboratories
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • L. Gore & Associates
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Johnson & Johnson
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Medtronic PLC
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Merit Medical Systems
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • MicroPort Scientific Corporation
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Penumbra
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
 

List of Tables

 
  • TABLE 1 Neurovascular Devices Market - Industry Snapshot & Key Buying Criteria, 2018 - 2026
  • TABLE 2 Global Neurovascular Devices Market, 2018 – 2026
  • TABLE 3 Global Neurovascular Devices Market Analysis by Product-2018
  • TABLE 4Global Neurovascular Devices Market Analysis by Technology-2018
  • TABLE 5 Global Neurovascular Devices Market Analysis by Application-2018
  • TABLE 7 Global Neurovascular Devices Market Analysis by Geography-2018
  • TABLE 8Global Neurovascular Devices Market Analysis by Leading Brands-2018
  • TABLE 9Neurovascular Devices Market - Key market driver analysis
  • TABLE 10Neurovascular Devices Market - Key market restraint analysis
  • TABLE 11North America Market Neurovascular DevicesLandscape Analysis, 2018-2026 (USD Mn)
  • TABLE 12U.S. Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 13Canada Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 14Europe Neurovascular Devices Market Landscape Analysis, 2018-2026 (USD Mn)
  • TABLE 15U.K Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 16 Germany Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 17 France Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 18 Italy Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 19 Spain Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 20Latin America Neurovascular Devices Market Landscape Analysis, 2018-2026 (USD Mn)
  • TABLE 21 Brazil Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 22 Mexico Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 20 Colombia Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 21 Asia Pacific Neurovascular Devices Market Landscape Analysis, 2018-2026 (USD Mn)
  • TABLE 22Japan Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 23China Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 24 India Neurovascular Devices Market Landscape Analysis, 2018-2026
  • TABLE 25North America Pricing Analysis
  • TABLE 26 North America Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 27 U.S. Pricing Analysis-2018
  • TABLE 28 Canada Pricing Analysis-2018
  • TABLE 29 Europe Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 30 U.K Pricing Analysis-2018
  • TABLE 31 Germany Pricing Analysis-2018
  • TABLE 32 France Pricing Analysis-2018
  • TABLE 33 Italy Pricing Analysis-2018
  • TABLE 34 Spain Pricing Analysis-2018
  • TABLE 35 Latin America Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 36 Brazil Pricing Analysis-2018
  • TABLE 37 Mexico Pricing Analysis-2018
  • TABLE 38 Colombia Pricing Analysis-2018
  • TABLE 39 Asia Pacific Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 40 Japan Pricing Analysis-2018
  • TABLE 41 China Pricing Analysis-2018
  • TABLE 42 India Pricing Analysis-2018
  • TABLE 43 Middle East Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 44 Saudi Arabia Pricing Analysis-2018
  • TABLE 45 South Africa Pricing Analysis-2018
 

List of Figures

 
  • 1 Neurovascular Devices Market Segmentation
  • 2 Market Size & Growth Prospects
  • 3 Leading Brand Dynamics
  • 4 Penetration & Growth Prospects
  • 5 Industry Analysis – Porter’s
  • 6 Neurovascular Devices Market – PESTEL Analysis
  • 7Neurovascular Devices Market Share by Product Type, 2018-2026
  • 8Neurovascular Devices Market Share by Cell Type, 2018-2026
  • 9 Neurovascular Devices Market Share by Technique, 2018-2026
  • 10 Neurovascular Devices Market Share by Application, 2018-2026
  • 11 Neurovascular Devices Market Share by End-Use, 2018-2026
  • 12 Neurovascular Devices Market Share by Region, 2018-2026

Key Insights Addressed:  

  • Defining market size from 2018 to 2026.
  • Estimating market growth till 2026 and consequence market forecast.
  • Identifying market drivers, restraints & future opportunities and allowing decision-maker with a range of possible outcomes and the probabilities that will occur for any choice of action.
  • Market segments and regions that will drive or lead market growth.
  • Defining Optimal Price Point (OPP) which will be accepted and recommended by maximum customers.
  • A bird’s-eye view of the competitive landscape and the key market players.
  • Key strategic growth driver adopted by market players. In-depth analysis of their strategies and implication on competition & growth.
    Key Findings:  
  • The Neurovascular Devices Market was valued at $2.08 Million in 2018 and is forecast to grow at a modest 5.5 % CAGR between 2018 and 2025, culminating in 2026 global sales of $3.8 Billion.
  • Neurovascular devices help in the treatment of several neurovascular disorders like intracranial atherosclerotic and cerebral aneurysms disease. The upsurge in the geriatric population and increase in a number of patients suffering from neurovascular disorders are anticipated to drive the market growth. Additionally, growth in acceptance of new minimally invasive techniques, for example, carotid artery stenting, and flow diversion lift the market growth.
  • We have segmented the Global Neurovascular Devices based on Application as Stroke, Cerebral Artery Stenosis, and Cerebral Aneurysm.
  • We have segmented the Global Neurovascular Devices based on Device Type as Cerebral embolization and aneurysm coiling devices, Cerebral angioplasty and stenting systems, Neurothrombectomy devices, and Support devices.
  • The key market participants includebbott Laboratories, W. L. Gore & Associates, Inc., Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Stryker Corp., and Terumo Medical Corporation.

Ameri Research implies a unique methodology of published information and primary research to bring key insights to customer decision making process. Our analytics model helps us to understand the structured and unstructured information from various sources. Key steps involves in the process are as below-

    1. Analyzing Published Information- Access to large pool of paid and unpaid published information via different sources and analyzing market trend.
    2. Setting Foundation- Input from analysis of secondary sources set our foundation to market analysis and helps in setting the scope for further research. Setting the scope involves Ameri Research proprietary statistical model, discussion with industry leaders, internal brainstorming, key discussion pointers from various forums etc.
    3. Need Gap Analysis- Defining the gap between our scope and availability of information.
    4. KOL Panel Discussion- Focused Group Discussion with a structured discussion guide to fine tune the gap and deriving the factors driving/restraining the market trend.
    5. Quantitative Research- Sampling large number of industry players, Education/Research Institutes, Government bodies, NGOs, Individual acclaimed researchers and conducting the primary interview with a structured questionnaire.
    6. Data Triangulation- We apply bottom-up demand approach or top-down estimation or a combined approach to triangulate the data points.
    7. Analyst Comment- Each of our analysts carries large pool of experience from domain perspective and add their value which is directional in nature
global-aesthetic-dermatology-market

To request a free sample copy of this report, please complete the form below verified and secure

We offer complete free customization that addresses client’s need. This includes insights from primary market research and a 60-minute free analyst consultation post report purchase.

This website is secure and your personal details are safe. Privacy policy

Description

The Neurovascular Devices Market was valued at $2.08Million in 2018 and is forecast to grow at a modest5.5 % CAGR between2018 and 2025, culminating in 2026 global sales of $3.8Billion.

 

Neurovascular devices help in the treatment of several neurovascular disorders like intracranial atherosclerotic and cerebral aneurysm disease. The upsurge in the geriatric population and increase in a number of patients suffering from neurovascular disorders are anticipated to drive the market growth. Additionally, growth in acceptance of new minimally invasive techniques, for example, carotid artery stenting,and flow diversion lift the market growth. So, the high cost of the medical devices and lack of neurosurgeons are projected to boost the market growth. According to WHO there are 800,000 people are suffering from strokes which are the fourth leading mortality factor in the U.S. in between them 76% people are having 65 ages and over is anticipated to grow by 59% from 800 million people in 2018 to 1.8 billion by 2028. Governing policies about medical devices fluctuate in different countries. To confirm maximum availability and safe procedure of medical devices, the union of guidelines for these devices is important. In Minimally invasive surgery helps to the patients as well as less blood loss, decrease pain, and cost-effectiveness will upsurge acceptance of neurovascular surgeries and the market growth. Some Major companies concentrating on new product launches by implementing innovative technologies to acquire market profits with better disease treatment.

Neurovascular Devices Market

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Global Neurovascular Devices”

 

Estimated Average product/ service cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

Due to the wide array of products available in the market, pricing, positioning, and sales channel optimization play a vital role in the success of a product. On average, in the China Global Neurovascular Devices are available at USD xxx- USD xxxx. However, high-end products are available at much higher prices. The prices in emerging countries and developed countries vary significantly due to the difference in purchasing power and availability of latest products.

 

Global Neurovascular DevicesMarket by “Application”

 

We have segmented the Global Neurovascular Devices based on Application as Stroke, Cerebral Artery Stenosis, and Cerebral Aneurysm.

 

We have observed that the rapid growth of Neurovascular Devices followed by Strokes Segment with 48%of the market shares over the forecast period. Due to the increase of motor impairment, people lost their function of arteries. There are 16 million people were affected by stroke per year which is expected to propel the neurovascular devices due to swift product revolutions by several companies in the upcoming years.

 

We also noticed that the significant growth of Neurovascular Devices followed by cerebral Aneurysm with a CAGR of 6.2% market share in 2018. Basically, 5% of people are suffering from this disease which may cause brain damage.

 

Global Neurovascular Devices Market by “Device Type”

 

We have segmented the Global Neurovascular Devices based on Device Type as Cerebral embolization and aneurysm coiling devices, Cerebral angioplasty and stenting systems, Neurothrombectomy devices, and Support devices.

 

We have observed that the rapid growth of Neurovascular Devices followed by Cerebral embolization and aneurysm coiling devices with 39% of the total revenue share over the forecast period. Due to the geriatric population and the occurrence of cerebrovascular disorders will help to develop this segment. Neurothrombectomy products are mainly used for patients who are unable for tissue plasminogen. These medical devices regain or destroy blood clots in the aneurysms by mechanical ultrasound techniques or lasers.

 

Regional Segmentation

 

The Asia Pacific and North America accounted for the maximum revenue share of over xx% in 2018 due to increased demand of Global Neurovascular Device followed by EU- Top 5 countries contribute $X.6 Billion in 2018 and expected to reach $x.5 Billion by 2026.

 

The rapid growth strokes and the availability of Global Neurovascular Devices materials option create an impact in developing countries for the demand for better health care device. China market will spectator health market growth at 4.9% CAGR during the forecast period. The growing burden of the aging population in China, that enhance the risk of stroke, aneurysm, and stenosis, drive the demand for neurovascular devices. According to Population and Migration data, the geriatric population in China is estimated to reach 2,387,792 by 2026. Furthermore, increasing R&D activities on neurovascular devices can support Chinese neurovascular devices market growth in the coming years. North America accounted for the largest market share of the total market in 2018. According to BAF(Brain Aneurysm Foundation), there are 6 million Americans suffer from an unruptured brain aneurysm. So, sophisticated healthcare infrastructure and advanced technology will propel the U.S. market over the forecast period.

 

“Competitive Landscape”and “Merger& Acquisition Insights”

 

The key market participants bbott Laboratories, W. L. Gore & Associates, Inc., Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Stryker Corp.,and Terumo Medical Corporation are few major players in Global Neurovascular Devices markets. TheGlobal Neurovascular Devices marketis fragmented with a large number of global & local players. Merger &Acquisitions, collaborations & new products launch are some of the major strategies adopted by key market players. Apart from this innovation& new product development are a major focus area for dominant companies.

 

Market Segmentation

 

Global Neurovascular DevicesMarket byApplication(Revenue, Million, 2018 – 2026)

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm

 

Global Neurovascular Devices Market by Device Type (Revenue, Million, 2018 – 2026)

  • Cerebral embolization and aneurysm coiling devices
  • Cerebral angioplasty and stenting systems
  • Neurothrombectomy devices
  • Support devices

 

Global Neurovascular Devices Market Regional Outlook (Revenue, USD Million, 2018-2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Global Neurovascular Devices Market Market Analytics,Global Neurovascular Devices Market Market Share, Global Neurovascular Devices Market Market Research,Global Neurovascular Devices Market Market Forecast, Global Neurovascular Devices Market Market Analysis,Global Neurovascular Devices Market Market Value, Global Neurovascular Devices Market Market Insight,Global Neurovascular Devices Market Market Trend, Global Neurovascular Devices Market Market Size,Global Neurovascular Devices Market Market Survey, Global Neurovascular Devices Market Market Research Report

Additional information

Price

Single User $3,650, Multiple User $4,650, Enterprise User $6650